Exhibit 99.1
Contacts: David Holmes – Investors
KCI
(210) 255-6892
Elliot Sloane – Media
Sloane & Company
(212) 446-1860
KINETIC CONCEPTS REPORTS
FOURTH QUARTER AND FULL YEAR
FINANCIAL RESULTS FOR 2006
Fourth Quarter Highlights
- V.A.C.® revenue increased 18% to $293.2 million from $248.6 million in the prior-year period
- Total revenue increased 15% to $371.5 million from $322.0 million in the prior-year period
- Share-based compensation expense under FAS 123R reduced net earnings by $4.0 million, or
$0.06 per diluted share
- Net earnings were $51.3 million, an increase of 11% from $46.4 million in the prior-year period
- Net earnings per diluted share were $0.73, an increase of 14% from $0.64 in the prior-year period
Full-Year Highlights
- V.A.C. revenue increased 18% to $1.07 billion from $907.5 million in the prior year
- Total revenue increased 13% to $1.37 billion from $1.21 billion in the prior year
- Share-based compensation expense under FAS 123R reduced net earnings by $12.0 million, or
$0.17 per diluted share
- Net earnings were $195.5 million, an increase of 60% from $122.2 million in the prior year
- Net earnings per diluted share were $2.69, an increase of 61% from $1.67 in the prior year
San Antonio, Texas, January 30, 2007 – Kinetic Concepts, Inc. (NYSE: KCI) today reported fourth quarter 2006 total revenue of $371.5 million, an increase of 15% from the fourth quarter of 2005. Total revenue for the full year of 2006 was $1.37 billion, a 13% increase from the prior year. Foreign currency exchange movements favorably impacted total revenue for the fourth quarter and full year of 2006 by 2% and 1%, respectively, compared to the corresponding periods of the prior year.
Net earnings for the fourth quarter of 2006 were $51.3 million, an 11% increase from $46.4 million for the same period last year. Net earnings per diluted share for the fourth quarter of 2006 increased 14% to $0.73 per diluted share compared to $0.64 per diluted share for the same period in the prior year. For the full year of 2006, net earnings were $195.5 million, up 60% from $122.2 million for the prior year. Net earnings per diluted share for the full year of 2006 were $2.69, an increase of 61% from last year.
During the third quarter of 2005, the Company reached an agreement to settle a 13-year old litigation case. The settlement payment resulted in a charge of $72.0 million, or $47.4 million and $0.65 per diluted share, net of taxes.
“I am pleased with our fourth quarter performance. The Company achieved a significant milestone of over one billion dollars in V.A.C. revenue during 2006,” said Catherine Burzik, President and Chief Executive Officer of KCI. “During my first few months here, we have begun to lay the foundation for what we expect will be a year of continued revenue growth, improved global processes and fiscal discipline.”
Revenue Recap – Fourth Quarter of 2006
Domestic revenue was $268.3 million for the fourth quarter of 2006, an increase of $28.5 million, or 12%, from the prior-year period due primarily to increased rental and sales volumes for V.A.C. wound healing devices and related disposables. Domestic V.A.C. revenue of $219.5 million for the fourth quarter was 13% higher than the same period one year ago due to an increase in V.A.C. rental units-in-use, partly offset by lower realized pricing and shorter average treatment periods. Growth in average rental units-in-use was reported across all care settings. Lower realized V.A.C. pricing resulted primarily from lower canister reimbursement rates under Medicare Part B and payer mix changes, while the average treatment period per unit-in-use declined year-to-year resulting in slightly lower dressing and canister usage per unit out.
Domestic surfaces revenue was $48.8 million for the fourth quarter of 2006, an 8% increase from the same period in the prior year due primarily to growth of both rental and sales volumes in the acute care setting.
International revenue of $103.2 million for the fourth quarter of 2006 increased 25% compared to the prior-year period due primarily to higher V.A.C. revenue. Fourth quarter international V.A.C. revenue of $73.7 million increased 36% compared to the year-ago period due primarily to continued market penetration. International surfaces revenue of $29.5 million for the fourth quarter increased 5% compared to the prior-year period. Foreign currency exchange movements favorably impacted total international revenue by 9% in the fourth quarter.
Revenue Recap – Full Year of 2006
Domestic revenue for 2006 was $993.8 million, up $107.6 million, or 12%, from 2005 due substantially to increased rental and sales volumes for V.A.C. wound healing devices and related disposables. International revenue for 2006 of $377.9 million, increased $55.5 million, or 17%, compared to the prior year due to higher V.A.C. unit volumes, partly offset by lower surfaces revenue due directly to a significant sale of $5.1 million in the first quarter of 2005. Foreign currency exchange movements favorably impacted total worldwide revenue by 1% for the year.
Worldwide V.A.C. revenue was $1.07 billion for 2006, an increase of 18% from the prior year due to increased market penetration resulting in higher rental and sales volumes. Foreign currency exchange movements favorably impacted worldwide V.A.C. revenue by 1% for the year.
Worldwide surfaces revenue was $302.5 million, an increase of less than 1% from the prior year. Foreign currency exchange movements favorably impacted worldwide surfaces revenue by 1% for the year. Negatively impacting worldwide surfaces revenue growth was a $5.1 million sale in 2005, which reduced growth over the prior year by 2%.
Gross Profit Margin
Gross profit for the fourth quarter and full year of 2006 was $177.1 million and $644.0 million, respectively, representing increases of 13% and 14%, respectively, from the same periods of the prior year. Gross profit margin for the fourth quarter of 2006 was 47.7% compared to 48.7% for the same period one year ago. For the full year of 2006, gross profit margin was 47.0%, up from 46.8% for the same period of the prior year. Fourth quarter 2006 gross profit margin was negatively impacted by lower homecare reimbursement for V.A.C. canisters in addition to higher selling costs, which were due to continued additions to our clinical sales force combined with share-based compensation costs.
Share-Based Compensation
During the fourth quarter and full year of 2006, the Company recorded share-based compensation expense totaling $5.7 million and $17.1 million, respectively, before income taxes, or $0.06 and $0.17, respectively, per diluted share, under the provisions of Statement of Financial Accounting Standards No. 123R. Prior to 2006, the Company accounted for share-based compensation under Accounting Principles Board Opinion No. 25.
Income Tax Rate
The effective income tax rate for the fourth quarter of 2006 was 34.7% compared to 34.0% in the prior-year period. The effective income tax rate for the full year of 2006 was 33.1% compared to 34.0% in 2005. The effective income tax rate for 2006 reflects the favorable resolution of certain tax contingencies during the first half of the year.
Other Matters
During the fourth quarter of 2006, the Company recorded CEO transition costs of approximately $2.7 million. The Company also made a voluntary prepayment of approximately $20 million on its senior debt outstanding during the fourth quarter of 2006. In connection with the prepayment, the Company wrote-off approximately $250,000 of capitalized debt issuance costs.
Outlook
The following guidance is based on current information and expectations as of January 30, 2007:
KCI currently projects full-year 2007 total revenue to be $1.51 – $1.56 billion, representing revenue growth of 10-14%, based primarily on continued demand for its V.A.C. negative pressure wound therapy devices and related supplies. The Company currently projects net earnings per diluted share for 2007 of $3.05 – $3.15 per diluted share, based upon a weighted average diluted share estimate of 70.5 – 71.5 million shares, representing diluted EPS growth of 13 – 17%.
The Company’s practice is to provide guidance on a full-year basis. However, the Company has historically experienced a seasonal fluctuation in sequential revenue between the fourth quarter and first quarter of each year. As a result of this historical experience, the Company currently expects that revenue in the first quarter of 2007 will approximate revenue in the fourth quarter of 2006.
Earnings Release Conference Call
As previously announced, we have scheduled an earnings release conference call for 8:30 a.m. eastern standard time today, Tuesday, January 30, 2007. The dial-in numbers for this conference call are as follows:
Domestic Dial-in Number: | 866-362-4832 |
International Dial-in Number: | +617-597-5364 |
Participant Code: | 32248120 |
This call is being webcast by CCBN and can be accessed at the Kinetic Concepts, Inc. web site at http://www.kci1.com/investor/index.asp, and clicking on Web cast – Q4 2006 Kinetic Concepts, Inc. Earnings Conference Call. The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com and institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com). An archive of the webcast will be available at http://www.kci1.com/investor/index.asp until January 29, 2008.
KCI's business outlook as of today is expected to be available on KCI's Investor Relations web site. It is currently expected that a business outlook update will not be announced until the release of KCI's next quarterly earnings announcement, notwithstanding subsequent developments. Although KCI undertakes no duty to update its business outlook, KCI may update the full business outlook or any portion thereof at any time.
About KCI
Kinetic Concepts, Inc. is a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces. We design, manufacture, market and service a wide range of proprietary products that can improve clinical outcomes and can help reduce the overall cost of patient care. Our advanced wound care systems incorporate our proprietary Vacuum Assisted Closureâ, or V.A.C., technology, which has been demonstrated clinically to help promote wound healing and can help reduce the cost of treating patients with serious wounds. Our therapeutic surfaces, including specialty hospital beds, mattress replacement systems and overlays, are designed to address pulmonary complications associated with immobility, to prevent skin breakdown and assist caregivers in the safe and dignified handling of obese patients. We have an infrastructure designed to meet the specific needs of medical professionals and patients across all health care settings, including acute care hospitals, extended care facilities and patients' homes both in the United States and abroad.
Forward-Looking Statements
This press release contains forward-looking statements including, among other things, management's outlook, estimates of future performance, revenue, earnings per share, growth objectives and weighted average shares outstanding. These forward-looking statements are based on our current expectations and are subject to a number of risks and uncertainties that could cause us to fail to achieve our current financial projections and other expectations, such as changes in the demand for the V.A.C. resulting from increased competition, payer reimbursement policies or our ability to protect our intellectual property rights. All information set forth in this release and its attachments is as of January 30, 2007. We undertake no duty to update this information. More information about potential factors that could cause our results to differ or adversely affect our business and financial results is included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2005 and in our Quarterly Reports on Form 10-Q for the quarterly periods ended September 30, 2006, June 30, 2006 and March 31, 2006, including, among other sections, under the captions, "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." These reports are on file with the SEC and available at the SEC's website at www.sec.gov. Additional information will also be set forth in those sections in our Annual Report on Form 10-K for the fiscal year ended December 31, 2006, which will be filed with the SEC on or before March 1, 2007.
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
Condensed Consolidated Statements of Earnings |
(in thousands, except per share data) |
(unaudited) |
| | |
| | |
| Three months ended December 31, | Year ended December 31, |
| | | % | | | | % |
| 2006 | 2005 | Change | 2006 | | 2005 | Change |
Revenue: | | | | | | | |
Rental | $ 262,929 | $ 229,366 | 14.6 % | $ 979,669 | | $ 858,098 | 14.2 % |
Sales | 108,562 | 92,659 | 17.2 | 391,967 | | 350,458 | 11.8 |
| _______ | _______ | | ________ | | ________ | |
Total revenue | 371,491 | 322,025 | 15.4 % | 1,371,636 | | 1,208,556 | 13.5 % |
| | | | | | | |
Rental expenses | 161,148 | 133,588 | 20.6 | 607,132 | | 528,000 | 15.0 |
Cost of sales | 33,270 | 31,673 | 5.0 | 120,492 | | 115,069 | 4.7 |
| _______ | _______ | | ________ | | ________ | |
Gross profit | 177,073 | 156,764 | 13.0 % | 644,012 | | 565,487 | 13.9 % |
| | | | | | | |
Selling, general and administrative expenses | 82,269 | 71,089 | 15.7 | 298,076 | | 253,869 | 17.4 |
Research and development expenses | 11,638 | 9,917 | 17.4 | 36,694 | | 30,614 | 19.9 |
Litigation settlement expense | - | - | - | - | | 72,000 | - |
| _______ | _______ | | ________ | | ________ | |
Operating earnings | 83,166 | 75,758 | 9.8 % | 309,242 | | 209,004 | 48.0 % |
| | | | | | | |
Interest income and other | 930 | 667 | 39.4 | 4,717 | | 4,189 | 12.6 |
Interest expense | (5,022) | (6,254) | (19.7) | (20,333) | | (25,152) | (19.2) |
Foreign currency gain (loss) | (455) | 82 | - | (1,580) | | (2,958) | (46.6) |
| _______ | _______ | | ________ | | ________ | |
Earnings before income taxes | 78,619 | 70,253 | 11.9 % | 292,046 | | 185,083 | 57.8 % |
| | | | | | | |
Income taxes | 27,281 | 23,886 | 14.2 | 96,578 | | 62,928 | 53.5 |
| _______ | _______ | | ________ | | ________ | |
Net earnings | $ 51,338 | $ 46,367 | 10.7 % | $ 195,468 | | $ 122,155 | 60.0 % |
| _______ | _______ | | ________ | | ________ | |
Net earnings per share: | | | | | | | |
Basic | $ 0.74 | $ 0.66 | 12.1 % | $ 2.76 | | $ 1.76 | 56.8 % |
| _______ | _______ | | ________ | | ________ | |
Diluted | $ 0.73 | $ 0.64 | 14.1 % | $ 2.69 | | $ 1.67 | 61.1 % |
| _______ | _______ | | ________ | | ________ | |
Weighted average shares outstanding: | | | | | | | |
Basic | 69,645 | 69,922 | | 70,732 | | 69,404 | |
| _______ | _______ | | ________ | | ________ | |
Diluted | 70,668 | 72,993 | | 72,652 | | 73,024 | |
| _______ | _______ | | ________ | | ________ | |
| | | | | | | |
|
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
Condensed Consolidated Balance Sheets |
(in thousands) |
(unaudited) |
| | | |
| December 31, |
| 2006 | | 2005 |
| | | |
Assets: | | | |
Current assets: | | | |
Cash and cash equivalents | $ 107,146 | | $ 123,383 |
Accounts receivable, net | 327,573 | | 281,890 |
Inventories, net | 43,489 | | 28,429 |
Deferred income taxes | 35,978 | | 26,447 |
Prepaid expenses and other current assets | 17,602 | | 16,908 |
| _______ | | _______ |
Total current assets | 531,788 | | 477,057 |
| | | |
Net property, plant and equipment | 217,471 | | 192,243 |
Debt issuance costs, less accumulated amortization of | | | |
$15,406 at 2006 and $12,709 at 2005 | 4,848 | | 7,545 |
Deferred income taxes | 7,903 | | 6,895 |
Goodwill | 49,369 | | 49,369 |
Other non-current assets, less accumulated amortization of | | | |
$9,757 at 2006 and $9,310 at 2005 | 31,063 | | 29,002 |
| _______ | | _______ |
| $ 842,442 | | $ 762,111 |
| _______ | | _______ |
Liabilities and Shareholders’ Equity: | | | |
Current liabilities: | | | |
Accounts payable | $ 38,543 | | $ 43,853 |
Accrued expenses and other | 189,801 | | 170,695 |
Current installments of long-term debt | 1,446 | | 1,769 |
Income taxes payable | 21,058 | | 18,619 |
| _______ | | _______ |
Total current liabilities | 250,848 | | 234,936 |
| | | |
Long-term debt, net of current installments | 206,175 | | 292,726 |
Deferred income taxes | 19,627 | | 30,622 |
Other non-current liabilities | 9,579 | | 12,361 |
| _______ | | _______ |
| 486,229 | | 570,645 |
| | | |
Shareholders' equity: | | | |
Common stock; authorized 225,000 at 2006 and 2005; | | | |
issued and outstanding 70,461 at 2006 and 70,307 at 2005 | 70 | | 70 |
Preferred stock; authorized 50,000 at 2006 and 2005; | | | |
issued and outstanding 0 at 2006 and 2005 | - | | - |
Additional paid-in capital | 575,539 | | 557,468 |
Deferred compensation | - | | (6,880) |
Retained deficit | (244,325) | | (365,916) |
Accumulated other comprehensive income | 24,929 | | 6,724 |
| _______ | | _______ |
Shareholders' equity | 356,213 | | 191,466 |
| _______ | | _______ |
| $ 842,442 | | $ 762,111 |
| _______ | | _______ |
KINETIC CONCEPTS, INC. AND SUBSIDIARIES | |
Condensed Consolidated Statements of Cash Flows | |
(in thousands) | |
(unaudited) | |
| Year ended December 31, | |
| 2006 | | 2005 | |
Cash flows from operating activities: | | | | |
Net earnings | $ 195,468 | | $ 122,155 | |
Adjustments to reconcile net earnings to net cash provided | | | | |
by operating activities: | | | | |
Depreciation, amortization and other | 83,407 | | 68,852 | |
Provision for bad debt | 13,744 | | 17,435 | |
Amortization of deferred gain on sale of headquarters facility | (1,070) | | (1,070) | |
Write-off of deferred debt issuance costs | 1,515 | | 2,941 | |
Share-based compensation expense | 17,107 | | 1,874 | |
Tax benefit related to exercise of stock options | - | | 27,459 | |
Excess tax benefit from share-based payment arrangements | (43,152) | | (27,459) | |
Change in assets and liabilities: | | | | |
Increase in accounts receivable, net | (55,986) | | (45,554) | |
Decrease (increase) in inventories, net | (14,505) | | 7,352 | |
Increase in current deferred income taxes | (9,531) | | (1,611) | |
Increase in prepaid expenses and other current assets | (2,527) | | (3,432) | |
Increase (decrease) in accounts payable | (4,850) | | 720 | |
Increase in accrued expenses and other | 19,769 | | 24,872 | |
Increase in income taxes payable | 48,218 | | 25,257 | |
Increase (decrease) in non-current deferred income taxes, net | (11,344) | | 18,407 | |
| _______ | | _______ | |
Net cash provided by operating activities | 236,263 | | 238,198 | |
| _______ | | _______ | |
Cash flows from investing activities: | | | | |
Additions to property, plant and equipment | (92,178) | | (94,225) | |
Decrease (increase) in inventory to be converted into equipment | | | | |
for short-term rental | (4,000) | | 2,300 | |
Dispositions of property, plant and equipment | 1,894 | | 2,508 | |
Increase in other non-current assets | (5,491) | | (417) | |
| _______ | | _______ | |
Net cash used by investing activities | (99,775) | | (89,834) | |
| _______ | | _______ | |
Cash flows from financing activities: | | | | |
Repayment of long-term debt, capital lease and other obligations | (87,684) | | (150,252) | |
Repurchase of common stock in open market transactions | (100,000) | | - | |
Excess tax benefit from share-based payment arrangements | 43,152 | | - | |
Proceeds from exercise of stock options | 11,937 | | 9,276 | |
Purchase of immature shares for minimum tax withholdings | (27,660) | | (7,589) | |
Proceeds from purchase of stock in ESPP and other | 3,830 | | 4,113 | |
| _______ | | _______ | |
Net cash used by financing activities | (156,425) | | (144,452) | |
| _______ | | _______ | |
Effect of exchange rate changes on cash and cash equivalents | 3,700 | | (4,895) | |
| _______ | | _______ | |
Net decrease in cash and cash equivalents | (16,237) | | (983) | |
| | | | |
Cash and cash equivalents, beginning of year | 123,383 | | 124,366 | |
| _______ | | _______ | |
Cash and cash equivalents, end of year | $ 107,146 | | $ 123,383 | |
| _______ | | _______ | |
| | | | |
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
Supplemental Revenue Data |
(in thousands) |
(unaudited) |
|
| Three months ended December 31, | |
| | | | | | Variance | |
| 2006 | | 2005 | | | $ | | % | |
Total Revenue: | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 200,718 | | $ 169,742 | | | $ 30,976 | | 18.2 % | |
Sales | 92,471 | | 78,860 | | | 13,611 | | 17.3 | |
| _______ | | _______ | | | ______ | | | |
Total V.A.C. | 293,189 | | 248,602 | | | 44,587 | | 17.9 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 62,211 | | 59,624 | | | 2,587 | | 4.3 | |
Sales | 16,091 | | 13,799 | | | 2,292 | | 16.6 | |
| _______ | | _______ | | | ______ | | | |
Total therapeutic surfaces/other | 78,302 | | 73,423 | | | 4,879 | | 6.6 | |
| | | | | | | | | |
Total rental revenue | 262,929 | | 229,366 | | | 33,563 | | 14.6 | |
Total sales revenue | 108,562 | | 92,659 | | | 15,903 | | 17.2 | |
| _______ | | _______ | | | ______ | | | |
Total Revenue | $ 371,491 | | $ 322,025 | | | $ 49,466 | | 15.4 % | |
| _______ | | _______ | | | ______ | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
USA Revenue: | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 164,032 | | $ 143,408 | | | $ 20,624 | | 14.4 % | |
Sales | 55,460 | | 51,018 | | | 4,442 | | 8.7 | |
| _______ | | _______ | | | ______ | | | |
Total V.A.C. | 219,492 | | 194,426 | | | 25,066 | | 12.9 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 40,469 | | 37,783 | | | 2,686 | | 7.1 | |
Sales | 8,292 | | 7,539 | | | 753 | | 10.0 | |
| _______ | | _______ | | | ______ | | | |
Total therapeutic surfaces/other | 48,761 | | 45,322 | | | 3,439 | | 7.6 | |
| | | | | | | | | |
Total USA rental | 204,501 | | 181,191 | | | 23,310 | | 12.9 | |
Total USA sales | 63,752 | | 58,557 | | | 5,195 | | 8.9 | |
| _______ | | _______ | | | ______ | | | |
Total – USA Revenue | $ 268,253 | | $ 239,748 | | | $ 28,505 | | 11.9 % | |
| _______ | | _______ | | | ______ | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
International Revenue: | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 36,686 | | $ 26,334 | | | $ 10,352 | | 39.3 % | |
Sales | 37,011 | | 27,842 | | | 9,169 | | 32.9 | |
| _______ | | _______ | | | ______ | | | |
Total V.A.C. | 73,697 | | 54,176 | | | 19,521 | | 36.0 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 21,742 | | 21,841 | | | (99) | | (0.5) | |
Sales | 7,799 | | 6,260 | | | 1,539 | | 24.6 | |
| _______ | | _______ | | | ______ | | | |
Total therapeutic surfaces/other | 29,541 | | 28,101 | | | 1,440 | | 5.1 | |
| | | | | | | | | |
Total International rental | 58,428 | | 48,175 | | | 10,253 | | 21.3 | |
Total International sales | 44,810 | | 34,102 | | | 10,708 | | 31.4 | |
| _______ | | _______ | | | ______ | | | |
Total – International Revenue | $ 103,238 | | $ 82,277 | | | $ 20,961 | | 25.5 % | |
| _______ | | _______ | | | ______ | | | |
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
Supplemental Revenue Data |
(in thousands) |
(unaudited) |
|
| Year ended December 31, | |
| | | | | | Variance | |
| 2006 | | 2005 | | | $ | | % | |
Total Revenue: | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 732,308 | | $ 615,579 | | | $ 116,729 | | 19.0 % | |
Sales | 336,781 | | 291,964 | | | 44,817 | | 15.4 | |
| ________ | | ________ | | | _______ | | | |
Total V.A.C. | 1,069,089 | | 907,543 | | | 161,546 | | 17.8 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 247,361 | | 242,519 | | | 4,842 | | 2.0 | |
Sales | 55,186 | | 58,494 | | | (3,308) | | (5.7) | |
| ________ | | ________ | | | _______ | | | |
Total therapeutic surfaces/other | 302,547 | | 301,013 | | | 1,534 | | 0.5 | |
| | | | | | | | | |
Total rental revenue | 979,669 | | 858,098 | | | 121,571 | | 14.2 | |
Total sales revenue | 391,967 | | 350,458 | | | 41,509 | | 11.8 | |
| ________ | | ________ | | | _______ | | | |
Total Revenue | $1,371,636 | | $1,208,556 | | | $ 163,080 | | 13.5 % | |
| ________ | | ________ | | | _______ | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
USA Revenue: | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 603,558 | | $ 519,570 | | | $ 83,988 | | 16.2 % | |
Sales | 204,703 | | 186,476 | | | 18,227 | | 9.8 | |
| ________ | | ________ | | | _______ | | | |
Total V.A.C. | 808,261 | | 706,046 | | | 102,215 | | 14.5 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 156,674 | | 152,294 | | | 4,380 | | 2.9 | |
Sales | 28,837 | | 27,853 | | | 984 | | 3.5 | |
| ________ | | ________ | | | _______ | | | |
Total therapeutic surfaces/other | 185,511 | | 180,147 | | | 5,364 | | 3.0 | |
| | | | | | | | | |
Total USA rental | 760,232 | | 671,864 | | | 88,368 | | 13.2 | |
Total USA sales | 233,540 | | 214,329 | | | 19,211 | | 9.0 | |
| ________ | | ________ | | | _______ | | | |
Total – USA Revenue | $ 993,772 | | $ 886,193 | | | $ 107,579 | | 12.1 % | |
| ________ | | ________ | | | _______ | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
International Revenue: | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 128,750 | | $ 96,009 | | | $ 32,741 | | 34.1 % | |
Sales | 132,078 | | 105,488 | | | 26,590 | | 25.2 | |
| ________ | | ________ | | | _______ | | | |
Total V.A.C. | 260,828 | | 201,497 | | | 59,331 | | 29.4 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 90,687 | | 90,225 | | | 462 | | 0.5 | |
Sales | 26,349 | | 30,641 | | | (4,292) | | (14.0) | |
| ________ | | ________ | | | _______ | | | |
Total therapeutic surfaces/other | 117,036 | | 120,866 | | | (3,830) | | (3.2) | |
| | | | | | | | | |
Total International rental | 219,437 | | 186,234 | | | 33,203 | | 17.8 | |
Total International sales | 158,427 | | 136,129 | | | 22,298 | | 16.4 | |
| ________ | | ________ | | | _______ | | | |
Total – International Revenue | $ 377,864 | | $ 322,363 | | | $ 55,501 | | 17.2 % | |
| ________ | | ________ | | | _______ | | | |